Attenuation of Immune Senescence Markers After Intensive Cancer Therapy Through Resistance Training: A Pilot Study.
- DOI
- 10.3390/cancers18111710
- Published
- 2026 May 24
- Container
- Cancers
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3390/cancers18111710,
title = {Attenuation of Immune Senescence Markers After Intensive Cancer Therapy Through Resistance Training: A Pilot Study.},
author = {Newell LF and Twohey E and Sweetnam J and Skendzel S and Stingle J and Vartanian KA and Davis BA and Layman CE and Carbone L and Ray K and Fei SS and Karstens L and He FC and El Jurdi N and Blaes AH and Meyers G and Cook RJ and Baraki A and Dengel DR and Holtan SG},
year = {2026},
journal = {Cancers},
doi = {10.3390/cancers18111710},
url = {https://doi.org/10.3390/cancers18111710}
}RIS
TY - JOUR TI - Attenuation of Immune Senescence Markers After Intensive Cancer Therapy Through Resistance Training: A Pilot Study. AU - Newell LF AU - Twohey E AU - Sweetnam J AU - Skendzel S AU - Stingle J AU - Vartanian KA AU - Davis BA AU - Layman CE AU - Carbone L AU - Ray K AU - Fei SS AU - Karstens L AU - He FC AU - El Jurdi N AU - Blaes AH AU - Meyers G AU - Cook RJ AU - Baraki A AU - Dengel DR AU - Holtan SG PY - 2026 JO - Cancers DO - 10.3390/cancers18111710 UR - https://doi.org/10.3390/cancers18111710 ER -
APA
LF, N., E, T., J, S., S, S., J, S., KA, V., BA, D., CE, L., L, C., K, R., SS, F., L, K., FC, H., N, E. J., AH, B., G, M., RJ, C., A, B., DR, D., & SG, H. (2026). Attenuation of Immune Senescence Markers After Intensive Cancer Therapy Through Resistance Training: A Pilot Study.. Cancers. https://doi.org/10.3390/cancers18111710
Source records
- pubmed · retrieved 2026-09-26T06:57:07.636Z